DARPA Harnessing Enzymatic Activity Lifesaving Remedies (HEALR) - 0 views
-
MiamiOH OARS on 29 Jun 20DARPA is soliciting innovative proposals to develop (1) new therapeutics against high-priority bacterial threats that leverage host-driven protein degradation or deactivation pathways; and (2) a platform capability to rapidly develop, screen, and optimize therapeutics against emerging bacterial threats.